CIK: 1229762 - Address: 22722 29Th Dr Se, Suite 100, Bothell, WA 98021
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret118-20-6-11-27-55-20
S%wins1007575506310077

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/15/16 17:52
6/13/16
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticJacobs CindyWAOEVP,CMOS.d-11.031-1-277D-68-61-830611-107-3-3-9-49-50
3/16/16 18:31
3/15/16
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticJacobs CindyWAOEVP,CMOS.d-30.83000-3-474D-93-64-67-293432116-4-6131-36-38
6/16/15 15:08
6/12/15
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticJacobs CindyWAOEVP,CMOS.d-42.692-1-265D-72-181819382810-1-31-10-9-58-61
5/21/15 18:29
5/20/15
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticJacobs CindyWAOEVP,CMOS.d-41.880-2-361D-82-50-14-16-18-66-3-214454824-52
8/14/14 18:11
8/13/14
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticJacobs CindyWAOEVP,CMOS.d-183.170-6-1243D-77-65-72-17-931250-3-5-35-36-4
3/18/14 19:23
3/17/14
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticJacobs CindyWAOEVP,CMOS.d-1512.254-1-429D-21135531690-5-1-1-23-76-80-86
10/7/13 15:26
8/19/13
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticJacobs CindyWAOEVP,CMOS.a-128.681-1-526D-2-38-14-8-3-3-1-2-1-1-22310-73
10/7/13 15:23
3/12/13
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticJacobs CindyWAOEVP,CMOS.a-611.901-1-223D-2-38-14-8-3-3-1-2-1-1-22310-73

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact